Company Filing History:
Years Active: 1995
Title: Olay Smidsrod - Innovator in Cellular Encapsulation
Introduction
Olay Smidsrod is a notable inventor hailing from Trondheim, Norway, recognized for his contributions to the field of biomedical engineering. With a focus on cellular encapsulation techniques, Smidsrod's innovative approach aims to improve transplantation methods, thereby enhancing patient outcomes.
Latest Patents
Olay Smidsrod holds a patent for a groundbreaking invention involving the encapsulation of cells in alginate. This specific method utilizes high-G alginate that provokes a reduced immune response during transplantation or implantation. The patented alginate contains a significant amount of .alpha.-L-guluronic acid, which is crucial to its effectiveness. Specifically, the alginate comprises over 50% .alpha.-L-guluronic acid, with preferences for at least 65% and ideally reaching 85%. The patented process involves suspending cells in a solution of high-G alginate, forming drops, and then contacting these drops with calcium ions to create microcapsules containing the cells. This innovative method holds potential for applications in medical therapies requiring low immune response.
Career Highlights
Olay Smidsrod has established himself as a key figure at Neocrin Company, where he works towards advancing technology in the field of biomedical applications. His work on cellular encapsulation has opened new avenues for research and practical applications in medical science.
Collaborations
Throughout his career, Olay Smidsrod has collaborated with esteemed colleagues such as Gudmund Skjak-Braek and Terje Espevik. These partnerships have played a significant role in driving research and development efforts, leading to advancements in encapsulation technologies that benefit various medical fields.
Conclusion
Olay Smidsrod's innovative work in the encapsulation of cells represents a significant advancement in biomedical engineering. His patent not only underscores his inventive contributions but also showcases the potential of alginate-based technologies in improving patient care through enhanced transplantation methods. With ongoing collaborations and research, Smidsrod continues to be a vital figure in the pursuit of medical innovations.